sr 33557 has been researched along with ammonium chloride in 1 studies
| Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (ammonium chloride) | Trials (ammonium chloride) | Recent Studies (post-2010) (ammonium chloride) |
|---|---|---|---|---|---|
| 50 | 3 | 1 | 5,385 | 71 | 436 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attal, M; Bordier, C; Chatelain, P; Chiron, M; Jaffrézou, JP; Laurent, G; Levade, T; Thurneyssen, O | 1 |
1 other study(ies) available for sr 33557 and ammonium chloride
| Article | Year |
|---|---|
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunotoxins; Indolizines; Lipidoses; Lymphoma, T-Cell; Monensin; Perhexiline; Phenethylamines; Ricin; Tumor Cells, Cultured; Verapamil | 1992 |